Cell Cryopreservation Market

The global market for cell cryopreservation had a value of $8.6 billion in 2023 and is projected to reach $63.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 22.2% from 2022 to 2030. Cryopreservation is a technique used to freeze tissues and cells at low temperatures in order to maintain their viability and prevent ice crystal formation, which can be detrimental to cells. It is commonly employed in the preservation of various biological materials such as microorganisms, tissue cells, embryos, nucleic acid, and proteins. Glycerol and dimethyl sulfoxide (DMSO) are commonly used substances in the cryopreservation process.

The COVID-19 pandemic had a positive impact on the cell cryopreservation market size. The postponement of transplants for benign hematological conditions due to infection and logistical constraints, as well as travel restrictions and concerns about contracting COVID-19 during the G-CSF mobilization period, led organizations to consider cell cryopreservation as a viable option.

The growth of the cell cryopreservation market is driven by increased research and development activities in the field of stem cells, government support for such activities, and the rise in chronic diseases. Additionally, factors such as the growing elderly population, increased infertility rates, advantages of cell freezing in drug development, and higher healthcare expenditure contribute to the market's growth.

However, the availability of alternative therapies for cell cryopreservation and the high maintenance costs associated with storage procedures hinder market growth. Nonetheless, manufacturers focusing on developing novel products for preserving various cells present opportunities in the cell cryopreservation market.

Impact of COVID-19 Pandemic on Cell Cryopreservation Market Size
The cell cryopreservation industry, like many other diagnostic and biotech industries, experienced a positive impact from the COVID-19 pandemic. According to data published in November 2023 by Blood Cell Therapy, the official journal of the Asia-Pacific Blood and Marrow Transplantation Group, hematopoietic progenitor cell (HPC) collection facilities had to continue operating during the pandemic while implementing safety measures based on national and international guidelines to ensure the secure collection of HPC products from both patients and donors. Initially, there was uncertainty surrounding the transportation of unrelated HPC products, leading to delays in unrelated transplants at healthcare centers. From March to October 2020, all transplants were either related allogeneic or autologous. Transplants for benign hematological conditions, such as thalassemia, were postponed from March to September 2020 due to the infection and logistical constraints. The combination of travel restrictions and the uncertainty of contracting COVID-19 during the period of G-CSF mobilization made it even more challenging to use freshly collected hematopoietic progenitor cell products for transplantation. In such situations, physicians preferred to request cryopreservation of all hematopoietic progenitor cell collections before administering preparative chemotherapy to the recipients.

Overall, the COVID-19 pandemic had a positive impact on the size of the cell cryopreservation market due to the postponement of transplants for benign hematological conditions caused by infection and logistical constraints. Additionally, travel restrictions and the uncertainty of contracting COVID-19 during the G-CSF mobilization period led organizations to consider cell cryopreservation as an alternative.

Cell cryopreservation Market Segmentation
Product Type
• Cryopreservation Media Agents
• Ethylene Glycol
• Dimethyl Sulfoxide
• Glycerol
• Others

Equipment
• Freezers
• Incubators
• Liquid Nitrogen Supply Tanks
• Others

Application
• Stem Cells
• Oocytes and Embryotic cells
• Sperm Cells
• Hepatocytes
• Others

End user
• Biopharmaceutical & Pharmaceutical Companies
• Academic and Research Institutes
• Biobanks
• Others

Region
• North America (U.S., Canada),
• Europe (UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway)
• Asia Pacific (Japan, China, India, Australia, Thailand, South Korea)
• Latin America (Brazil, Mexico, Argentina),
• Middle East & Africa (Saudi Africa, South Arabia, UAE, Kuwait)

Market By Type Segment Review
The market is categorized into two main types: cryopreservation media and equipment. Within the cryopreservation media type, there are further segments based on the agent used. The cryopreservation media segment is divided into ethylene glycol, dimethyl sulfoxide, glycerol, and others. On the other hand, the equipment type is subdivided into freezers, liquid nitrogen supply tanks, and others. In 2023, the cryopreservation media segment held the largest market share and is expected to maintain this dominance throughout the forecast period. This can be attributed to the growing utilization of cryopreservation media in preserving cells for the development of cell therapy, as well as the increasing prevalence of chronic diseases.

Market By Application Segment Review
The market is divided into several applications, including stem cells, oocytes cells, sperm cells, and others. In 2023, the "others" segment held the largest market share and is expected to maintain its dominance in the forecast period. This is primarily due to the increasing incidences of chronic diseases related to blood and a rise in research and development activities focused on treating such diseases. Furthermore, the growing preference for using cryopreserved cells in the treatment of chronic diseases contributes to the overall market growth.

Market By End User Segment Review
By end user, the market is classified into pharmaceutical and biotechnology company, research institute, others. The pharmaceutical and biotechnology company segment accounted for the major share of the market in 2023 and is anticipated to continue this trend throughout the forecast period, owing to surge in number of pharmaceutical, biotechnology companies, which is mainly due to increase in demand for pharmaceutical and biotechnology products.

Market By Region Review
In 2023, North America emerged as the leading region in the cell cryopreservation market and is projected to maintain its dominant position in the forecast period. This can be attributed to the high prevalence rate of chronic diseases, an increase in the number of market players, and a rise in infertility rates within the region. However, the Asia-Pacific region is expected to experience the highest compound annual growth rate (CAGR) during the forecast period. This is primarily due to the presence of densely populated countries like India and China, which consequently leads to a higher prevalence rate of chronic diseases and a growing geriatric population. Additionally, the Asia-Pacific region is witnessing a surge in product launches and other market trends adopted by industry players, further driving the growth of the cell cryopreservation market in the region.

Key Market Players
Eppendorf Corporate, Corning Inc, HIMEDIA LABORATORIES, PromoCell GmbH, Sartorius AG, Cytiva, Lonza, ThermoFisher Inc., Sigma Aldrich, Creative Biolabs

Key Benefits For Stakeholders
• This report presents a detailed quantitative analysis of market segments, current trends, estimations, and dynamics in the cell cryopreservation market from 2023 to 2030. The objective is to identify the prevailing opportunities in the cell cryopreservation market.
• The market research provides comprehensive information about key drivers, restraints, and opportunities influencing the market.
• Porter's five forces analysis is utilized to highlight the influence and power of buyers and suppliers. This analysis enables stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
• A thorough analysis of the cell cryopreservation market segmentation helps identify the current market opportunities.
• Major countries in each region are carefully mapped based on their revenue contribution to the global market.
• Market player positioning aids in benchmarking and provides a clear understanding of the current position of market players.
• The report includes an analysis of regional and global cell cryopreservation market trends, key players, market segments, application areas, and market growth strategies.